SCHEMBL24364492

SCHEMBL24364492

Cc1cncc(NC(=O)C(=O)N2[C@@H](c3ccccc3)CC[C@H](C)[C@@H]2C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 20/20 1.00
▸ WDR77 Q9BQA1 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29980737 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL24364491 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL24366422 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL29980489 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL24367170 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL24367242 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL24363971 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL24365449 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL30470875 1.00 PRMT5 (1.00) PRMT5WDR77
SCHEMBL30470652 1.00 PRMT5 (1.00) PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228478-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2024-07-11 — — US disclosed
US-20220127256-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2022-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127256-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 PRMT5 347/4885WDR77 1263/4885
US-20240228478-A1 COMPOUNDS AND METHODS OF USE F12, C1R, ABCG2 PRMT5 347/4885WDR77 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback